Methamphetamine Hydrochloride
Methamphetamine Hydrochloride
3 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it3 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Hikma Pharmaceuticals USA Inc. | unknown | 1 | SUPPLYING |
| Dr.Reddy's laboratories Limited | unknown | 1 | SUPPLYING |
| Mayne Pharma Commercial LLC | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jan 27, 2026RESOLVEDShortage resolved: Methamphetamine Hydrochloride Tablet (Dr. Reddy's Laboratories, Inc.)
Methamphetamine Hydrochloride Tablet — reported in shortage by Dr. Reddy's Laboratories, Inc.. Therapeutic category: Psychiatry.
- Jan 27, 2026RESOLVEDShortage resolved: Methamphetamine Hydrochloride Tablet (Hikma Pharmaceuticals USA, Inc.)
Methamphetamine Hydrochloride Tablet — reported in shortage by Hikma Pharmaceuticals USA, Inc.. Therapeutic category: Psychiatry.
- Mar 17, 2023SHORTAGEDrug shortage: Methamphetamine Hydrochloride Tablet (Dr. Reddy's Laboratories, Inc.)
Methamphetamine Hydrochloride Tablet — reported in shortage by Dr. Reddy's Laboratories, Inc.. Therapeutic category: Psychiatry.
- Mar 17, 2023SHORTAGEDrug shortage: Methamphetamine Hydrochloride Tablet (Hikma Pharmaceuticals USA, Inc.)
Methamphetamine Hydrochloride Tablet — reported in shortage by Hikma Pharmaceuticals USA, Inc.. Therapeutic category: Psychiatry.
Pill